🔗 Share this article

The prestigious award in Physiology or Medicine has been granted for revolutionary discoveries that clarify how the immune system attacks dangerous infections while protecting the healthy tissues.

Three esteemed scientists—Japan's Shimon Sakaguchi and American scientists Mary Brunkow and Fred Ramsdell—received this honor.

Their research identified specialized "sentinels" within the immune system that remove rogue immune cells capable of attacking the organism.

The findings are now enabling innovative therapies for immune disorders and cancer.

These winners will share a prize fund worth 11 million Swedish kronor.

Crucial Findings

"The research has been decisive for comprehending how the immune system functions and why we don't all develop serious autoimmune diseases," stated the head of the award panel.

This team's research explain a core mystery: How does the immune system protect us from numerous invaders while keeping our healthy cells intact?

The immune system employs white blood cells that search for signs of infection, even pathogens and bacteria it has not met before.

Such cells employ detectors—known as recognition units—that are generated by chance in a vast number of variations.

That provides the defense network the capacity to fight a wide array of threats, but the randomness of the process unavoidably creates white blood cells that can attack the host.

Protectors of the Body

Scientists previously understood that a portion of these problematic white blood cells were destroyed in the thymus—the site where immune cells mature.

This year's Nobel Prize recognizes the identification of regulatory T-cells—described as the immune system's "security guards"—which travel through the body to disarm other defenders that assault the body's own tissues.

It is known that this mechanism malfunctions in self-attack conditions such as type-1 diabetes, MS, and RA.

The Nobel panel added, "The findings have laid the foundation for a novel area of research and accelerated the development of new treatments, for instance for cancer and immune disorders."

Regarding malignancies, T-regs prevent the system from attacking the tumor, so research are focused on lowering their numbers.

For autoimmune diseases, experiments are exploring boosting T-reg cells so the body is no longer under attack. A similar approach could also be effective in minimizing the chances of transplanted organ failure.

Pioneering Experiments

Professor Shimon Sakaguchi, of Osaka University, performed tests on rodents that had their immune gland extracted, leading to self-attack conditions.

The researcher demonstrated that injecting defense cells from other animals could prevent the illness—implying there was a system for blocking defenders from attacking the host.

Mary Brunkow, from the Institute for Systems Biology in a US city, and Fred Ramsdell, currently at Sonoma Biotherapeutics in a California city, were studying an genetic immune disorder in rodents and humans that led to the discovery of a genetic factor critical for how T-regs function.

"Their pioneering research has uncovered how the immune system is controlled by regulatory T cells, preventing it from accidentally attacking the healthy cells," commented a leading biological science expert.

"This work is a remarkable example of how basic biological research can have far-reaching consequences for public health."